Bryhali (Halobetasol Propionate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Bryhali. Always confirm against the full prescribing information.
74 interactions
Acarbose
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Acarbose.
Level 1 evidence
Alogliptin
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Alogliptin.
Level 1 evidence
Bendroflumethiazide
The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Bendroflumethiazide.
Level 1 evidence
Bexagliflozin
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Bexagliflozin.
Level 1 evidence
Bromocriptine
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Bromocriptine.
Level 1 evidence
Canagliflozin
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Canagliflozin.
Level 1 evidence
Chlorothiazide
The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Chlorothiazide.
Level 1 evidence
Cholestyramine
Cholestyramine may increase the excretion rate of Ulobetasol which could result in a lower serum level and potentially a reduction in efficacy.
Level 1 evidence
Cyclosporine
The risk or severity of adverse effects can be increased when Ulobetasol is combined with Cyclosporine.
Level 1 evidence
Dapagliflozin
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Dapagliflozin.
Level 1 evidence
Digoxin
The risk or severity of adverse effects can be increased when Ulobetasol is combined with Digoxin.
Level 1 evidence
Disopyramide
The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Disopyramide.
Bryhali (Halobetasol Propionate) has 74 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Bryhali (Halobetasol Propionate) has 0 major, 68 moderate, and 6 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Bryhali. Always confirm against the full prescribing information.